As new cancer vaccines—led by Moderna and Merck’s mRNA-4157—near pivotal trial readouts, the FDA’s vaccines czar Peter Marks, M.D., Ph.D., said the agency is ready to review the shots despite AI-related unknowns. “We are ready to review—we’re open for business,” Marks, director of the FDA’s Center for Biologics Evaluation and […]
On the Pathogenesis of Turbo Cancer Induced by COVID-19 mRNA Vaccines: a Hypothesis.
This short memo makes the case that turbo cancers in patients who received mRNA vaccines can be explained by the observed uptake of those vaccines by macrophages and dendritic cells, based on a well-documented but not widely known theory of carcinogenesis. An increasing number of clinical oncologists and pathologists are […]
Report 61: Histopathology Series Part 3 – Ute Krüger, MD, Breast Cancer Specialist, Reveals Increase in Cancers and Occurrences of “Turbo Cancers” Following Genetic Therapy “Vaccines”
This report is Part 3 in a series. It follows Part 1, “Report 56: Autopsies Reveal Medical Atrocities of Genetic Therapies Being Used Against a Respiratory Virus,” and Part 2, “Report 58: Part 2 – “Autopsies Reveal Medical Atrocities of Genetic Therapies Being Used Against a Respiratory Virus.” A […]